Please upgrade your browser.
A CANCER patient from Yorkshire has become the first in the world to trial a new drug experts hope will become part of a new generation of treatments against the disease.
Not only did Bob meet Elvis Presley, he also ended up with a bottle of the King's Vaseline Hair Tonic. Inspired by this anecdote, I asked readers to send me their accounts of encounters with the famous.
A CANCER patient last night said he felt "completely abandoned" after health chiefs refused to pay for a new drug which could prolong his life.
Proposals to use these agents as neoadjuvant therapy have generated significant controversy, Dr. Van Poppel said.
Agent shows high preoperative sensitivity, specificity, data indicate.
The launch of Sanofi Pasteur MSD's Gardasil and GSK's Cervarix has propelled cancer vaccines from research obscurity to a key area of commercial and clinical interest. But can the sector capitalise on these gains and really fulfil its promise?
MDCT represents the diagnostic mainstay for the detection and staging of RCC. In the wake of new systemic therapies for advanced RCC, including angiogenesis inhibitor drugs, monitoring treatment response may become a new task for crosssectional imaging.
Tumours with an immunopositivity for serotonin had a longer RCCspecific survival and tumours with an immunopositivity for CD56 and NSE had a shorter RCCspecific survival but the difference was not significant.
Pfizer Oncology (NYSE: PFE) will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets.
Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis - Abstract
Department of Urology, University of Munich, Klinikum Grosshadern, Marchioninistr. 15, 81377, Munchen, Germany.
|Powered by NeonCRM|